Company registration number 05500551 (England and Wales)
MED BEDS LIMITED
AMENDED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MED BEDS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
MED BEDS LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investment property
4
405,000
405,000
Current assets
Debtors
5
910
1,775
Cash at bank and in hand
2,040
5,224
2,950
6,999
Creditors: amounts falling due within one year
6
(309,185)
(280,219)
Net current liabilities
(306,235)
(273,220)
Total assets less current liabilities
98,765
131,780
Provisions for liabilities
(12,300)
(12,300)
Net assets
86,465
119,480
Capital and reserves
Called up share capital
7
1,000
1,000
Profit and loss reserves
85,465
118,480
Total equity
86,465
119,480

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 28 October 2025
Mr M Holling
Director
Company registration number 05500551 (England and Wales)
MED BEDS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Med Beds Limited is a private company limited by shares incorporated in England and Wales. The registered office is 39/43 Bridge Street, Swinton, Mexborough, South Yorkshire, England, S64 8AP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net o f sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Investment properties
Investment property is included at fair value. Gains are recognised in the income statement. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.
1.4
Financial instruments
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

MED BEDS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
MED BEDS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
4
Investment property
2025
£
Fair value
At 1 April 2024 and 31 March 2025
405,000
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
910
1,775

Other Debtors consist of Prepayments and Accrued Income £910 (2024 - £1,775)

6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
-
0
77
Taxation and social security
1,638
2,950
Other creditors
307,547
277,192
309,185
280,219

Creditors within one year consist of Directors' Loan Account £207,907 (2024 - £174,742), Share Holders Current Account £98,434 (2024 - £98,434) and Accruals and Deferred Income £1,206 (2024 - £1,163)

7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary 'A' shares of £1 each
500
500
500
500
Ordinary 'B' shares of £1 each
500
500
500
500
1,000
1,000
1,000
1,000
2025-03-31 2024-04-01 false false false 28 October 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr M Holling Mrs S Holling 05500551 2024-04-01 2025-03-31 05500551 2025-03-31 05500551 2024-03-31 05500551 core:WithinOneYear 2025-03-31 05500551 core:WithinOneYear 2024-03-31 05500551 core:CurrentFinancialInstruments 2025-03-31 05500551 core:CurrentFinancialInstruments 2024-03-31 05500551 core:ShareCapital 2025-03-31 05500551 core:ShareCapital 2024-03-31 05500551 core:RetainedEarningsAccumulatedLosses 2025-03-31 05500551 core:RetainedEarningsAccumulatedLosses 2024-03-31 05500551 core:ShareCapitalOrdinaryShareClass1 2025-03-31 05500551 core:ShareCapitalOrdinaryShareClass1 2024-03-31 05500551 core:ShareCapitalOrdinaryShareClass2 2025-03-31 05500551 core:ShareCapitalOrdinaryShareClass2 2024-03-31 05500551 core:ShareCapitalOrdinaryShares 2025-03-31 05500551 core:ShareCapitalOrdinaryShares 2024-03-31 05500551 bus:Director1 2024-04-01 2025-03-31 05500551 2023-04-01 2024-03-31 05500551 2024-03-31 05500551 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 05500551 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 05500551 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 05500551 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 05500551 bus:OrdinaryShareClass1 2025-03-31 05500551 bus:OrdinaryShareClass1 2024-03-31 05500551 bus:OrdinaryShareClass2 2025-03-31 05500551 bus:OrdinaryShareClass2 2024-03-31 05500551 bus:AllOrdinaryShares 2025-03-31 05500551 bus:AllOrdinaryShares 2024-03-31 05500551 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 05500551 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 05500551 bus:FRS102 2024-04-01 2025-03-31 05500551 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 05500551 bus:CompanySecretary1 2024-04-01 2025-03-31 05500551 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP